Banner Publications MH200828 N141

Publications

Christian Blank Reset all filters

Results found: 52

Showing results: 51 - 52

The Lancet. Oncology

Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study.

OncoTargets and therapy

Synchronous BRAF(V600E) and MEK inhibition leads to superior control of murine melanoma by limiting MEK inhibitor induced skin toxicity.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.